Antibiotic-lock therapy and erythromycin for treatment of catheter-related Candida parapsilosis and Staphylococcus aureus infections.
Wu
Chao-Yi
CY
Lee
Ping-Ing
PI
D000293:Adolescent; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018441:Biofilms / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology; D002404:Catheterization / Q000009:adverse effects*; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012778:Short Bowel Syndrome / Q000150:complications / Q000601:surgery; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D004917:Erythromycin; D000666:Amphotericin B